Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/8190
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDave, Dhruti-
dc.date.accessioned2019-02-19T11:11:28Z-
dc.date.available2019-02-19T11:11:28Z-
dc.date.issued2018-05-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/8190-
dc.descriptionSDR00315en_US
dc.description.abstractBiotherapeutics or large molecules such as Monoclonal Abs when administered in the patient can generate unwanted immune response by the production of neutralizing Abs.The Assessment of the Neutralizing Ab becomes important to understand the immunogenic response of a Drug/ Biopharmaceutic for which the Ligand Binding Neutralizing Assay can be developed. With the help of Nab assay,the presence of Neutralizing Ab production against the Therapeutics can be detected.en_US
dc.language.isoen_USen_US
dc.publisherInstitute of Science, Nirma Universityen_US
dc.relation.ispartofseries;SDR00315-
dc.subjectBiotechnologyen_US
dc.subjectProject Reporten_US
dc.subjectProject Report 2018en_US
dc.subjectBiotechnology Project Report 2018en_US
dc.subject16MBCen_US
dc.subject16MBC007en_US
dc.titleDevelopment of a Ligand binding assay for detection of Neutralizing antibodies against Monoclonal Antibody X in Human Serumen_US
dc.typeDissertationen_US
Appears in Collections:Dissertation, BT

Files in This Item:
File Description SizeFormat 
SDR00315.pdf4.95 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.